Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics. (Q52885510)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2016
edit
Language Label Description Also known as
English
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.
scientific article published in February 2016

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit